Sarepta Therapeutics (SRPT) PT Lowered to $187 at RBC Capital
Tweet
Share
E-mail
Get Alerts SRPT Hot Sheet
Price: $15.31 +2.07%
Rating Summary:
18 Buy, 19 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Rating Summary:
18 Buy, 19 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Join SI Premium – FREE
RBC Capital lowered its price target on Sarepta Therapeutics (NASDAQ: SRPT) to $187.00 (from $189.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Adobe (ADBE) PT Lowered to $225 at UBS Amid Plans to Pivot to Freemium Model
- RLJ Lodging Trust (RLJ) PT Raised to $10 at Truist Securities
- Marvell (MRVL) PT Raised to $345 at B.Riley, bullish on new CEO
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
